https://www.thebodypro.com/author/howard-grossman
Howard Grossman, M.D. Img

Howard Grossman, M.D.

Howard Grossman is a board-certified internist with a private practice in Manhattan. He is a general practitioner, but is most widely known as a specialist in HIV medicine. His work with people affected by HIV lead him to become one of the plaintiffs in the landmark suit Vacco v. Quill, et al., which sought to overturn laws preventing terminally-ill patients from obtaining their physicians' help to end their own lives. The case was decided in 1997, with the Supreme Court finding no constitutional guarantee of "the right to die," but leaving the door open for states to experiment with various options. Dr. Grossman earned a B.A. in political science at Haverford College and studied medicine at SUNY Downstate College of Medicine in Brooklyn. He did his residency at Kings County Hospital, one of the largest public hospitals in Brooklyn. It was there that he saw some of the first cases of AIDS in the early 1980s. Dr. Grossman worked at St. Clare's Hospital, at the first dedicated AIDS unit in the country and entered private practice in 1987. He has one of the largest HIV practices in New York and serves a diverse patient population. Dr. Grossman is an Assistant Attending Physician at St. Luke's-Roosevelt Hospital Center in Manhattan and is an Associate Professor of Clinical Medicine at Columbia University College of Physicians and Surgeons. He has become nationally recognized as an educator on HIV and as an advocate for gay and lesbian civil rights and the rights of People with HIV. Dr. Grossman has served as a consultant to many pharmaceutical companies including Glaxo-Wellcome, Abbott, Hoffman-LaRoche, Ortho Biotech, Janssen, Agouron and Bristol-Myers Squibb. He has also worked with government panels at the National Institutes of Health and the Food and Drug Administration. Dr. Grossman has been involved with multiple community-based organizations and has served on the boards of the Gay Men's Health Crisis and the People with AIDS Health Group. He is actively involved with the Treatment Activists Group (TAG), a group which has had a profound impact on drug development and availability.

Latest by Howard Grossman, M.D.

Promo Image
Features

The Overlooked Secondary Benefits of PrEP

PrEP has been nothing short of revolutionary in changing the landscape of HIV prevention. What has been less discussed are the enormous secondary benefits that have followed the introduction of PrEP.

Health Insurance Companies Are the Biggest Impediment to PEP and PrEP for HIV Prevention -- A Blog Entry by Howard Grossman, M.D. Img

Health Insurance Companies Are the Biggest Impediment to PEP and PrEP for HIV Prevention -- A Blog Entry by Howard Grossman, M.D.

What will it take to force the insurance industry to treat HIV prevention as the emergency it is, and to stop creating systems that promote increased infections?

I'm an HIV Physician. And I'm Starting PrEP. A Blog Entry by Howard Grossman, M.D. Img
Men Who Have Sex With Men

I'm an HIV Physician. And I'm Starting PrEP. A Blog Entry by Howard Grossman, M.D.

I am a doctor who specializes in LGBT health and HIV medicine. I have spent the last 30 years working to help my patients who have HIV live with the illness and trying to help those who are HIV negative stay that way. I am also a 60-year-old gay man ...

Promo Image

Greater Suppression of CD8 Activation with Four vs. Three Drugs in Early Stages of Primary HIV Infection (PHI) Despite Similar Plasma Virological Decay Rates

To view a video of this presentation, click here Please note: Best viewed with Internet Explorer.(Requires Real Player for Windows or Macintosh)

Greater Suppression of CD8 Activation with Four vs. Three Drugs in Early Stages of Primary HIV Infection...

Promo Image

Impact of Treatment Interruption on Plasma Viral Load, CD4 Count and Virtual Phenotypes (Virco) in HIV Patients Who Failed Multiple Courses of Antiretroviral Therapy

To view a video of this presentation, click here Please note: Best viewed with Internet Explorer.(Requires Real Player for Windows or Macintosh)

Impact of Treatment Interruption on Plasma Viral Load, CD4 Count and Virtual Phenotypes (Virco) in HIV P...

Promo Image

Metabolic and Anthropometric Changes Observed in HIV-Infected Patients Treated With Combivir (ZDV/3TC) Plus Nelfinavir or Nevirapine (A Substudy of the COMBINE Study)

Click here to view the original abstract.

Metabolic and Anthropometric Changes Observed in HIV-Infected Patients Treated with Combivir (ZDV/3TC) Plus Nelfinavir or Nevirapine (A Substudy of the COMBINE Study) (Poster 506) Authored by Fisac, C.; ...